MTI013
Product Specifications
Target
Opioid Receptor|||SARS-CoV
Related Pathways
GPCR/G Protein|||Endocrinology/Hormones|||Neuroscience|||Microbiology/Virology
Bioactivity
MTI013 is a selective inhibitor of SARS-CoV-2 nsp14 Mtase (IC50: 2.98 µM) and an antiviral agent (IC50: 10.33 µM in HCoV-229E infected Huh7 cells) . Additionally, MTI013 demonstrates synergistic antiviral effects when used in conjunction with the RdRp inhibitor SHEN26.
Smiles
O=C(C1=CC(CSC[C@H]2[C@H](O)[C@@H](O)[C@H](N3C(N=CN=C4N)C4N=C3)O2)=CC=C1)NC5=CC=CC=C5
Molecular Formula
C24H26N6O4S
Molecular Weight
494.57
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15346809 1 Vial
Lentiviral human PTPRB shRNA (UAS) - Lentiviral human PTPRB shRNA (UAS) (25)
Ask
View Details 